progesterone - CISMeF

Preferred Label : progesterone;

MeSH definition : The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS.;

MeSH synonym : pregnenedione;

Wikipedia automatic translation : Progestogen;

MeSH hyponym : progesterone, (17 alpha)-Isomer; progesterone, (13 alpha,17 alpha)-( -)-Isomer; Progesterone, (9 beta,10 alpha)-Isomer;

MeSH CAS label : Pregn-4-ene-3,20-dione;

MeSH Related Number : progesterone, (17 alpha)-Isomer; progesterone, (9 beta,10 alpha)-Isomer; progesterone, (13 alpha,17 alpha)-( -)-Isomer; 2000-66-0 ((17 alpha)-isomer); 2755-10-4 ((9 beta,10 alpha)-isomer); 57-83-0 (Progesterone); 59952-90-8 ((13 alpha,17 alpha)-( -)-isomer);

Registry Number MeSH : 57-83-0;

Related CAS MeSH : 2000-66-0 (Progesterone, (17 alpha)-Isomer); 2755-10-4 (Progesterone, (9 beta,10 alpha)-Isomer); 59952-90-8 (Progesterone, (13 alpha,17 alpha)-( -)-Isomer);

Wikipedia link : https://en.wikipedia.org/wiki/Progestogen;

Codes EINECS : 200-350-6;

Is substance : O;

UNII : 4G7DS2Q64Y;

InChIKey : RJKFOVLPORLFTN-LEKSSAKUSA-N;

Details

Origin ID

D011374;

UMLS CUI

C0033308;

ATC code(s)
- progesterone and estrogen [ATC Code]
ATC code(s)
- progesterone [ATC Code]
- progesterone and estrogen [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- progesterone [Substance BNPC]
- progesterone deficiency [Disease (Nov.)]
Currated CISMeF NLP mapping
- Progesterone [ICD-11 Extension code]
- Progesterone [ICHI extension code]
- Progesterone [NCIt concept]
- Progesterone [LOINC component]
- Progesterone (substance) [SNOMED CT concept]
- progesterone [Radlex concept]
- progesterone [SNOMED Notion]
Indexing information
- 3,17-dihydroxy-7-(4-hydroxyphenyl)-androst-5-ene 3,17-diacetate [MeSH Supplementary Concept]
- 3,17-dihydroxy-7-(4-methoxyphenyl)-androst-5-ene 3,17-diacetate [MeSH Supplementary Concept]
- ZK 136798 [MeSH Supplementary Concept]
Pharmacological action(s)
- progestins [MeSH Descriptor]
Record concept(s)
- Progesterone, (9 beta,10 alpha)-Isomer [MeSH concept]
- progesterone [MeSH concept]
- progesterone, (13 alpha,17 alpha)-(+-)-Isomer [MeSH concept]
- progesterone, (17 alpha)-Isomer [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1-dehydroprogesterone [MeSH Supplementary Concept]
- 11 alpha-diazoacetate progesterone [MeSH Supplementary Concept]
- 11,19-oxidoprogesterone [MeSH Supplementary Concept]
- 11-ketoprogesterone [MeSH Supplementary Concept]
- 11-progesteryl-2-carboxymethyltyramine-4-(10-methyl)acridinium-9-carboxylate [MeSH Supplementary Concept]
- 11-progesteryl-2-succinoyltyramine-4-(10-methyl)acridinium-9-carboxylate [MeSH Supplementary Concept]
- 11beta-aminoprogesterone [MeSH Supplementary Concept]
- 12 alpha,17'-epoxy-17 alpha-methylprogesterone [MeSH Supplementary Concept]
- 15 alpha-hydroxy-11-oxoprogesterone [MeSH Supplementary Concept]
- 16 alpha,17-epoxyprogesterone [MeSH Supplementary Concept]
- 16 beta-methyl-16 alpha,17 alpha-epoxyprogesterone [MeSH Supplementary Concept]
- 16,17-cyclohexano-4,5-dihydroprogesterone [MeSH Supplementary Concept]
- 16,17-cyclopropanoprogesterone [MeSH Supplementary Concept]
- 16-cysteinyl-progesterone [MeSH Supplementary Concept]
- 16-dehydroprogesterone [MeSH Supplementary Concept]
- 16-methyl-17-benzoyloxypregnen-4-en-3,20-dione [MeSH Supplementary Concept]
- 16-methylprogesterone [MeSH Supplementary Concept]
- 17-(phenylseleno)progesterone [MeSH Supplementary Concept]
- 17-acetoxy-6,16-dimethylene-4-pregnene-3,20-dione [MeSH Supplementary Concept]
- 17-acetoxy-6-methylene-4-pregnene-3,20-dione [MeSH Supplementary Concept]
- 17-acetoxy-9-fluoro-6-methylprogesterone [MeSH Supplementary Concept]
- 17-acetyl-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydrocyclopenta(a)phenanthren-3-ylidenecarbamoyloxy)ethyl)trimethylammonium [MeSH Supplementary Concept]
- 17-aminopregn-4-ene-3,20-dione [MeSH Supplementary Concept]
- 17-hydroxy-6-dehydroprogesterone [MeSH Supplementary Concept]
- 17-hydroxymethylprogesterone [MeSH Supplementary Concept]
- 17-hydroxyprogesterone linoleic acid ester [MeSH Supplementary Concept]
- 17-hydroxyprogesterone-3-O-carboxymethyloxime [MeSH Supplementary Concept]
- 17-methoxymethylprogesterone [MeSH Supplementary Concept]
- 17-p-bromophenylcarbamoyloxypregn-4-ene-3,20-dione [MeSH Supplementary Concept]
- 17-phenylcarbamoyloxypregn-4-ene-3,20-dione [MeSH Supplementary Concept]
- 18-ethylenedithioprogesterone [MeSH Supplementary Concept]
- 18-ethynylprogesterone [MeSH Supplementary Concept]
- 18-oxo-18-vinylprogesterone [MeSH Supplementary Concept]
- 18-vinylprogesterone [MeSH Supplementary Concept]
- 2'-methyl-16,17-cyclohexaneprogesterone [MeSH Supplementary Concept]
- 2-cyanoprogesterone [MeSH Supplementary Concept]
- 2-hydroxy-4-pregnene-3,20-dione [MeSH Supplementary Concept]
- 2-hydroxymethyleneprogesterone [MeSH Supplementary Concept]
- 21,21-dichloroprogesterone [MeSH Supplementary Concept]
- 21-(phenylseleno)progesterone [MeSH Supplementary Concept]
- 21-acetylaminoprogesterone [MeSH Supplementary Concept]
- 21-acryloxyprogesterone [MeSH Supplementary Concept]
- 21-chloroprogesterone [MeSH Supplementary Concept]
- 21-hydroxy-11,19-oxidopregn-4-ene-3,20-dione [MeSH Supplementary Concept]
- 21-hydroxy-6,19-oxidopregn-4-ene-3,20-dione [MeSH Supplementary Concept]
- 21-hydroxy-6,19-oxidoprogesterone [MeSH Supplementary Concept]
- 21-hydroxyethylthioprogesterone [MeSH Supplementary Concept]
- 21-succinyloxy-6,19-epoxyprogesterone [MeSH Supplementary Concept]
- 3,20-dioxopregn-4-ene-18'-carboxaldehyde cyclic 18'-(1,2-ethandiylmercaptal) [MeSH Supplementary Concept]
- 4-cyanoprogesterone [MeSH Supplementary Concept]
- 4-pregnene-3,20-dione [MeSH Supplementary Concept]
- 4-pregnene-3,20-dione-21-oic acid [MeSH Supplementary Concept]
- 6 alpha-methyl-16 alpha,17 alpha-cyclohexylpregn-4-en-3,20-dione [MeSH Supplementary Concept]
- 6 beta-hydroperoxyprogesterone [MeSH Supplementary Concept]
- 6,19-methanoprogesterone [MeSH Supplementary Concept]
- 6,19-oxidoprogesterone [MeSH Supplementary Concept]
- 6-alpha-methyl-progesterone [MeSH Supplementary Concept]
- 6-azaprogesterone [MeSH Supplementary Concept]
- 6-bromoprogesterone [MeSH Supplementary Concept]
- 6-fluoroprogesterone [MeSH Supplementary Concept]
- 6-methylene-4-pregnene-3,20-dione [MeSH Supplementary Concept]
- 6-methylprogesteron-17-pivalate [MeSH Supplementary Concept]
- 7-(carboxyethylthio)progesterone [MeSH Supplementary Concept]
- 7-carboxymethyl progesterone [MeSH Supplementary Concept]
- MVP protocol 1 [MeSH Supplementary Concept]
- SGE-102 [MeSH Supplementary Concept]
- TX-001HR [MeSH Supplementary Concept]
- Utrogestan [MeSH Supplementary Concept]
- allylestriol [MeSH Supplementary Concept]
- autoimmune progesterone dermatitis [MeSH Supplementary Concept]
- caproxyprogesterone [MeSH Supplementary Concept]
- crinone [MeSH Supplementary Concept]
- estradiol benzoate, progesterone drug combination [MeSH Supplementary Concept]
- flumedroxone acetate, meprobamate, n-pentylhydroflumethiazide drug combination [MeSH Supplementary Concept]
- hydroxyprogesterone hemisuccinate bovine serum albumin tetramethylrhodamine isothiocyanate [MeSH Supplementary Concept]
- implix [MeSH Supplementary Concept]
- menstrogen [MeSH Supplementary Concept]
- nepapakistamine A [MeSH Supplementary Concept]
- nymfon-orion [MeSH Supplementary Concept]
- pentarane A [MeSH Supplementary Concept]
- pentarane B [MeSH Supplementary Concept]
- pregn-5-ene-3,20-dione [MeSH Supplementary Concept]
- progest [MeSH Supplementary Concept]
- progestasert (progesterone-IUD) [MeSH Supplementary Concept]
- progesterone 11-succinyltyrosine methyl ester [MeSH Supplementary Concept]
- progesterone 12-succinyltyrosine methyl ester [MeSH Supplementary Concept]
- progesterone 17 alpha-hydroperoxide [MeSH Supplementary Concept]
- progesterone 3-(O-carboxymethyl)oxime-bovine serum albumin [MeSH Supplementary Concept]
- progesterone 6-hemimaleate [MeSH Supplementary Concept]
- progesterone 6-hemisuccinate [MeSH Supplementary Concept]
- progesterone-11-bovine serum albumin [MeSH Supplementary Concept]
- progesterone-11-hemisuccinyl-bovine serum albumin [MeSH Supplementary Concept]
- progesterone-11HS-horseradish peroxidase [MeSH Supplementary Concept]
- progesterone-20-(O-methyloxime) [MeSH Supplementary Concept]
- progesterone-3-(O-carboxymethyl oxime)-horseradish peroxidase [MeSH Supplementary Concept]
- progesterone-3-(O-carboxymethyl)oximinoiodohistamine [MeSH Supplementary Concept]
- progesterone-3-ethanolimine [MeSH Supplementary Concept]
- proligestone [MeSH Supplementary Concept]
- quingestrone [MeSH Supplementary Concept]
- sterolibrin [MeSH Supplementary Concept]
- uracil-progesterone [MeSH Supplementary Concept]
- vaganine D [MeSH Supplementary Concept]
See also
- receptors, progesterone [MeSH Descriptor]
See also inter- (CISMeF)
- Product containing progesterone (medicinal product) [SNOMED CT concept]
- Progesterone [MedDRA Preferred Term]
- Progesterone derivative (substance) [Inactive SNOMED CT concept]
- progesterone preparation [SNOMED Notion]
Semantic type(s)
- Hormone [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing progesterone (medicinal product) [SNOMED CT concept]
- Progesterone [NCIt concept]
- Progesterone [LOINC component]
- Progesterone (substance) [SNOMED CT concept]
- Therapeutic Progesterone [NCIt concept]
- progesterone [ATC Code]
- progesterone [SNOMED Notion]
- progesterone deficiency [Disease (Nov.)]
- progesterone preparation [SNOMED Notion]
Validated automatic mappings to BTNT
- Therapeutic Progesterone [NCIt concept]
- progesterone [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients